17 and 23: prime numbers for ankylosing spondylitis?
- PMID: 24035251
- PMCID: PMC3857094
- DOI: 10.1016/S0140-6736(13)61913-3
17 and 23: prime numbers for ankylosing spondylitis?
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Comment on
-
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.Lancet. 2013 Nov 23;382(9906):1705-13. doi: 10.1016/S0140-6736(13)61134-4. Epub 2013 Sep 13. Lancet. 2013. PMID: 24035250 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
